G. Michael Landis
Known title: Chief Financial OfficerCIK: 0001548560
G. Michael Landis's purchase track record
G. Michael Landis has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/18/2026 | PLYX | $8K | +17.0% | -25.3% | +12.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| PLYX | ▲ Buy | Open Market | 2,867 | $8K | 2/18/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
PLYX Included in List of 20 Premarket Movers
Polaryx Therapeutics (PLYX) was featured in a Benzinga report listing 20 stocks moving in premarket trading. The article highlights Webuy Global as a primary driver of market movement, with PLYX included in the broader list of active tickers. No specific reasons for PLYX's price action were detailed in the provided summary. The stock currently trades near its 52-week low, with technical indicators showing a support rejection at $2.06.
PLYX Included in List of 20 Premarket Movers. Polaryx Therapeutics (PLYX) was featured in a Benzinga report listing 20 stocks moving in premarket trading. The article highlights Webuy Global as a primary driver of market movement, with PLYX included in the broader list of active tickers. No specific reasons for PLYX's price action were detailed in the provided summary. The stock currently trades near its 52-week low, with technical indicators showing a support rejection at $2.06.